USD 43.12
(-0.65%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 6.44 Billion ZAR | 38.36% |
2023 | 5.68 Billion ZAR | 74.04% |
2022 | 3.26 Billion ZAR | -24.7% |
2021 | 4.33 Billion ZAR | -2.49% |
2020 | 4.44 Billion ZAR | 61.0% |
2019 | 2.76 Billion ZAR | -33.23% |
2018 | 4.13 Billion ZAR | 8.53% |
2017 | 3.81 Billion ZAR | 10.68% |
2016 | 3.44 Billion ZAR | 10.03% |
2015 | 3.12 Billion ZAR | 7.68% |
2014 | 2.9 Billion ZAR | 8.48% |
2013 | 2.67 Billion ZAR | 8.71% |
2012 | 2.46 Billion ZAR | 7.77% |
2011 | 2.28 Billion ZAR | 9.87% |
2010 | 2.08 Billion ZAR | 14.96% |
2009 | 1.81 Billion ZAR | 11.51% |
2008 | 1.62 Billion ZAR | 15.31% |
2007 | 1.4 Billion ZAR | -9.92% |
2006 | 1.56 Billion ZAR | 16.47% |
2005 | 1.34 Billion ZAR | 15.19% |
2004 | 1.16 Billion ZAR | -16.72% |
2003 | 1.39 Billion ZAR | 13.43% |
2002 | 1.23 Billion ZAR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q4 | 214.39 Million USD | 0.0% |
2024 Q2 | 207.1 Million USD | 0.0% |
2023 FY | 5.68 Billion ZAR | 74.04% |
2023 Q4 | 197.4 Million USD | 0.0% |
2023 Q2 | 194.4 Million USD | 0.0% |
2022 FY | 3.26 Billion ZAR | -24.7% |
2022 Q4 | 199.68 Million USD | 0.0% |
2022 Q2 | 206.74 Million USD | 0.0% |
2021 Q4 | 200.72 Million USD | 0.0% |
2021 Q2 | 186.12 Million USD | 0.0% |
2021 FY | 4.33 Billion ZAR | -2.49% |
2020 Q4 | 153.09 Million USD | 0.0% |
2020 Q2 | 190.86 Million USD | 0.0% |
2020 FY | 4.44 Billion ZAR | 61.0% |
2019 FY | 2.76 Billion ZAR | -33.23% |
2019 Q4 | 202.63 Million USD | 0.0% |
2018 FY | 4.13 Billion ZAR | 8.53% |
2017 FY | 3.81 Billion ZAR | 10.68% |
2016 FY | 3.44 Billion ZAR | 10.03% |
2015 FY | 3.12 Billion ZAR | 7.68% |
2014 FY | 2.9 Billion ZAR | 8.48% |
2013 FY | 2.67 Billion ZAR | 8.71% |
2012 FY | 2.46 Billion ZAR | 7.77% |
2011 FY | 2.28 Billion ZAR | 9.87% |
2010 FY | 2.08 Billion ZAR | 14.96% |
2009 FY | 1.81 Billion ZAR | 11.51% |
2008 FY | 1.62 Billion ZAR | 15.31% |
2007 FY | 1.4 Billion ZAR | -9.92% |
2006 FY | 1.56 Billion ZAR | 16.47% |
2005 FY | 1.34 Billion ZAR | 15.19% |
2004 FY | 1.16 Billion ZAR | -16.72% |
2003 FY | 1.39 Billion ZAR | 13.43% |
2002 FY | 1.23 Billion ZAR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alternative Energy Partners, Inc. | 3437.19 USD | -187603523.89% |
Allstar Health Brands, Inc. | 215.74 Thousand USD | -2988721.629% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 55.24 Million USD | -11572.863% |
Café Serendipity Holdings, Inc. | 1.43 Million USD | -448854.807% |
Decision Diagnostics Corp. | - USD | -Infinity% |
Health Advance Inc. | 47.57 Thousand USD | -13555277.339% |
HealthWarehouse.com, Inc. | 13.79 Million USD | -46641.674% |
LIGAND PHARMACEUTICAL INC | 78.2 Million USD | -8145.372% |
MedGen, Inc. | 16.59 USD | -38868553245.389% |
Omni Health, Inc. | 1.14 Million USD | -562074.964% |
Oxford Investments Holdings Inc. | 373.76 Thousand USD | -1725145.01% |
Pineapple, Inc. | 452.94 Thousand USD | -1423527.657% |
ScripsAmerica, Inc. | 31.4 Million USD | -20433.092% |